0001104659-21-134647.txt : 20211104
0001104659-21-134647.hdr.sgml : 20211104
20211104214527
ACCESSION NUMBER: 0001104659-21-134647
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211102
FILED AS OF DATE: 20211104
DATE AS OF CHANGE: 20211104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROCHE HOLDING LTD
CENTRAL INDEX KEY: 0000889131
STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 8880 [8880]
STATE OF INCORPORATION: V8
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40969
FILM NUMBER: 211382095
BUSINESS ADDRESS:
STREET 1: ROCHE HOLDING, LTD.
STREET 2: GRENZACHERSTRASSE 124
CITY: BASEL
STATE: V8
ZIP: CH-4070
BUSINESS PHONE: 9732354295
MAIL ADDRESS:
STREET 1: ROCHE HOLDING, LTD.
STREET 2: GRENZACHERSTRASSE 124
CITY: BASEL
STATE: V8
ZIP: CH-4070
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROCHE FINANCE LTD
CENTRAL INDEX KEY: 0001053942
STATE OF INCORPORATION: V8
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40969
FILM NUMBER: 211382094
BUSINESS ADDRESS:
STREET 1: C/O HOFFMAN LA ROCHE
STREET 2: 124 GRENSACHERSTRASSE CH 4002
CITY: BASEL SWITZERLAND
STATE: V8
MAIL ADDRESS:
STREET 1: C/O HOFFMAN LA ROCHE
STREET 2: 124 GRENSACHERSTRASSE CH 4002
CITY: BASEL SWITZERLAND
STATE: V8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Entrada Therapeutics, Inc.
CENTRAL INDEX KEY: 0001689375
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813983399
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6 TIDE STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 857-305-1825
MAIL ADDRESS:
STREET 1: 6 TIDE STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: CycloPorters, Inc.
DATE OF NAME CHANGE: 20161104
4
1
tm2132054-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-11-02
0
0001689375
Entrada Therapeutics, Inc.
TRDA
0000889131
ROCHE HOLDING LTD
C/O ENTRADA THERAPEUTICS, INC.
6 TIDE STREET
BOSTON
MA
02210
0
0
1
0
0001053942
ROCHE FINANCE LTD
C/O ENTRADA THERAPEUTICS, INC.
6 TIDE STREET
BOSTON
MA
02210
0
0
1
0
Common Stock
2021-11-02
4
C
0
2495385
A
2495385
I
See Footnote
Common Stock
2021-11-02
4
C
0
318140
A
2813525
I
See Footnote
Series A Preferred Stock
2021-11-02
4
C
0
2495385
0
D
Common Stock
2495385
0
I
See Footnote
Series B Preferred Stock
2021-11-02
4
C
0
318140
0
D
Common Stock
318140
0
I
See Footnote
Each share of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. These amounts reflect a 1-for- 7.235890014 reverse stock split which became effective on October 22, 2021. The Series A Preferred Stock and Series B Preferred Stock have no expiration date.
Represents shares held by Roche Finance Ltd ("Roche Finance"). Roche Finance is a wholly owned subsidiary of Roche Holding Ltd ("Roche Holding"), a Swiss corporation whose shares are traded on the SIX Swiss Exchange. Roche Holding is the indirect beneficial owner of these securities of the Issuer. This Form 4 shall not be deemed an admission that any reporting person or other person is a beneficial owner of any securities of the Issuer for any purpose, other than the securities reported in this Form 4.
/s/ Jared Cohen, as Attorney-in-Fact
2021-11-04